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Abstract 
Background: The Celina Water Department treats and supplies surface water contaminated by 
cyanotoxins from Grand Lake Saint Marys (GLSM) to approximately 12,000 customers in 
Celina, Ohio. Cyanotoxins are a biochemically and bioactively diverse group of extremely potent 
natural toxins in water. A common cyanotoxin called microcystin-LR found in GLSM has been 
associated with acute liver damage and potentially liver and colorectal cancer.  
Methods: In this observational study, the city of Celina (Mercer County) Ohio that had a 
contaminated surface water supply, the cancer incidence was compared with two control cities, 
St. Marys, and Wapakoneta (Auglaize County) in Ohio, both served by ground water. Cases 
were identified through the Ohio Cancer Incidence Surveillance System (OCISS) registry 
from1996-2008. Cumulative age adjusted incidence rates (IRs) for hepatocellular carcinoma 
(HCC) and colorectal cancer (CRC) were calculated. The cumulative IR, and 95% confidence 
interval (95% CI) of CRC and HCC were also compared with the IR in Ohio and the 
Surveillance, Epidemiology and End Results database.   
Results: Celina had the lowest cumulative IR of HCC 2.4/100,000 compared to 
Wapakoneta 5.3/100,000 and Saint Marys 4.0/100,000 people. The IR for HCC was not 
significantly different than the Ohio or SEER rates (P> 0.05). CRC rates in Celina were 
78.4/100,000 which was lower than Wapakoneta 82.9/100,000. However, the CRC IR and 95% 
CI were significantly higher (P< 0.05) for all 3 cities when compared to either Ohio or national 
SEER rates. 
Conclusion: There is inconclusive evidence to support that cyanotoxins from GLSM are 
associated with excess risk of cancer from drinking water.  
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Introduction
Surface water (SW) is often used for drinking water supplies. The water quality varies
widely depending upon many environmental and anthropogenic factors. Toxic cyanobacteria or 
blue-green algae are often part of the normal phytoplankton population in surface waters. These 
cyanobacteria show incredible morphological diversity (Pearson, Mihali, Moffitt, Kellmann, & 
Neilan, 2010). In relatively clean water with limited nutrients (oligotrophic), the distribution of 
cyanobacteria is relatively low (Falconer, 2005). When water becomes polluted (eutrophic) from
nutrient enrichment, cyanobacteria populations can proliferate exuberantly and often a single or a 
few species predominate (Falconer, 2005).  
Like algae, cyanobacteria are photosynthetic but the individual cells lack an organized 
nucleus and do not contain chloroplasts thus making them more like bacteria. Individual 
organisms are too small to be seen with the naked eye, however, in eutrophic conditions the 
cyanobacteria can form algal blooms which can often be seen on the surface of water. The 
blooms may be several inches thick, particularly near the shoreline or may be suspended in the 
water column at various depths. The underlying reasons that promote these blooms are not 
completely understood, but it is thought that it may be related to nutrients added naturally and 
through man-made sources such as fertilizer runoff (Carmichael & Falconer, 1993; Rapala, 
Sivonen, Lyra, & Niemela, 1997).  
According to Falconer (2005), one factor that may contribute to dominance of a single 
species of cyanobacteria is the ability to produce toxins. The production of natural toxins by a 
particular strain of cyanobacteria may be a form of natural selection through suppressing 
consumption by other organisms. Cyanotoxins can either be water soluble or lipid-soluble. There 
are currently about 40 known species of cyanobacteria capable of producing toxins, however, at 
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any particular time, cyanobacteria may or may not be producing toxin (Westrick, Szlag, 
Southwell, & Sinclair, 2010). By comparison, according to a literature review in 1994, only 12 
different species of cyanobacteria had been shown to produce toxins (Carmichael, 1994). 
Water-soluble cyanotoxins are of particular concern to drinking water because they can 
pass through a conventional water treatment plant utilizing coagulation, flocculation, 
sedimentation and filtration processes (Falconer, 2005). Certain cyanotoxins are resistant to 
boiling and chemical disinfection, so they could be present in the distribution system and 
ultimately at the consumer’s tap water if proper treatment strategies are not employed. Typically, 
public water systems do not monitor or treat for cyanotoxins either in source or finished water 
because cyanotoxins are not regulated in the United States (U.S.) under any National Primary 
Drinking Water Regulation (NPDWR). 
According to the Ohio Environmental Protection Agency (OEPA), GLSM covers 
approximately 13,500 acres. It is roughly 9 miles long, 3 miles wide and average about 7 feet 
deep with a soft bottom of silt. GLSM was constructed around 1850 as part of the Miami-Erie 
Canal and was at one time the world’s largest man-made lake before Lake Mead was formed as a 
result of construction of the Hoover Dam in 1935. GLSM is enriched with phosphorous as a 
result of runoff from years of fertilizer and manure application to fields. This has decreased the 
water quality by increasing turbidity, decreasing dissolved oxygen and increasing concentrations 
of nitrogen and phosphorous. According to the OEPA, approximately 90% of the land in the 
GLSM watershed is utilized for crop and livestock production. The Ohio Department of Natural 
Resources (ODNR) estimated that currently between 150,000 and 200,000 tons of 
phosphorous-laden silt enters GLSM every year.  
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Chlorophyll (a), a green pigment found in cyanobacteria, plants and algae is not specific 
to toxin producing cyanobacteria however it is a measure of algal productivity. The following 
(Figure 1) shows the levels of chlorophyll (a) and total phosphorous levels in GLSM during the 
summer of 2010. 
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Figure 1. Total phosphorous and chlorophyl1 (a) in Grand Lake Saint Marys—2010. 
In 2007, the OEPA participated in the National Lake Assessment which required 
sampling for the presence of microcystin-LR at GLSM, a common water soluble cyanotoxin, 
along with 18 other lakes in Ohio. The microcystin-LR levels in GLSM were very high (78 
µg/L) relative to samples taken in the other lakes in Ohio. This level was significantly higher 
than the 1 µg/L benchmark criterion for drinking water established by World Health 
Organization (WHO). It was almost 4 times the WHO benchmark criterion for the upper end of 
the moderate risk range for exposure in recreational waters. In the summer of 2009, the total 
microcystin levels at the intake to the Celina water treatment plant (WTP) in GLSM were 
recorded as high as 70.3 parts per billion (ppb) recorded on August 11, 2009 and analyzed by the 
enzyme-linked immunosorbent assay (ELISA) method. The limit of quantitation (LOQ) was 0.15 
µg/L. The LOQ is the lowest limit that can be reliably measured by an analytical procedure. 
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Levels throughout the summer of 2009 ranged from 42.3-69.0 ppb. Through the summer of 2010 
and up to until September of 2011 the levels ranged between 2.3-43.4 µg/L at the Celina WTP 
intake. The levels are monitored weekly by the Celina Water Department at the intake and 
throughout the plant including finished water. The levels may have wide variance from one week 
to the next. On November 2, 2011 microcystin was detected at the intake at 41.8 µg/L and on 
November 8, 2011, the level was 29.8 µg/L. A one way ANOVA test for significance was 
performed to determine if there was a difference in microcystin levels between 2010 and 2011 
(null hypothesis) Ho: (µg/L) concentrations are equal for period January-October 2010 vs. the 
same period in 2011. The mean microcystin level for 2011 was 12.4 µg/L and during the same
period for 2010, the level was 4.1 µg/L (P= 0.000158) (n= 38 measurements). The P = <0.05 
indicate levels in 2011 were significantly higher, in fact 3 times higher than for the same period 
in 2010. The microcystin levels at the Celina WTP intake for 2010 and 2011 are found in Figure 
2. 
Total Microcystin (µg/L) at Intake to the Celina WTP
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Figure 2. Total microcystin levels (µg/l) at intake to Celina WTP—2010 and 2011.  

Adapted from data on OEPA HAB website: http://www.epa.ohio.gov/Default.aspx?tabid=5149 

 
 
 
6 EVALUATION OF CANCER FROM EXPOSURE TO CYANOTOXINS
When ingested in sufficient concentrations, cyanotoxins may cause acute gastrointestinal 
illness and/or affect the liver or central nervous systems in mammals and fish (Chiswell et al., 
1997). Skin contact with contaminated water may result in skin rash or irritations. Four classes of 
cyanotoxins that have been detected at GLSM are as follows: microcystin, cylindrospermopsin, 
anatoxin-a, and saxitoxin. The HABs at GLSM have produced cyanotoxin contamination of 
water that has caused a serious public health concern. Eight people from five adjoining counties 
fell ill during the summer of 2010 with symptoms likely linked to GLSM contaminated water 
through recreational contact. Of primary interest for this research, the city of Celina has been 
using GLSM as source water for their drinking water treatment plant for almost 60 years. The 
Celina WTP serves approximately 12,000 customers in the City of Celina and East Jefferson 
District. The Celina WTP has been using GLSM as source water since February 25, 1952. In 
1994, the City began construction of a dual ozone/peroxide treatment system for controlling taste 
and odor problems. In 2008, the water plant installed granular activated carbon (GAC) into the 
treatment process train. The GAC was initially installed to adsorb dissolved organic carbon in 
the source water that reacts with chlorine during the disinfection process to form disinfection 
by-products such as haloacetic acids and trihalomethanes, both regulated with maximum
contaminant levels (MCLs) of 60 and 80 µg/L respectively. GAC is also effective for the 
physical removal of the two classes of soluble cyanotoxins most problematic for drinking water 
including cylindrospermopsin and microcystins (Falconer, 2005).  
The Ohio Department of Health had 21 reports of illness from exposure to the water at 
GLSM in 2010. However only eight of those reports fit the case definition for “probable” 
meaning the report meets the criteria for “suspect” case and there is laboratory documentation of 
a harmful algal bloom (HAB) in the water. The definition of suspect case according to the Ohio 
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Department of Health (ODH) is “exposure to water or to seafood with a confirmed algal bloom
and onset of associated signs and symptoms within a reasonable time after exposure and without 
identification of another cause”. A confirmed case meets the criteria of a “probable case” 
combined with professional judgment based upon medical review. Of the 21 reports, 12 were 
ultimately classified as “not a case” after extensive review, and one report was lost to follow-up 
in spite of repeated attempts to contact the individual for an interview. In addition to the human 
illness, three dog deaths were linked to the HAB at GLSM. The data provided by the ODH are 
presented in the following table (Table 1): 
Table 1 
Human Illness Report Grand Lake Saint Marys 2010 
Toxin Reported Yes
County Auglaize & Mercer
Probable illness 8 
Lost to follow up 1 
Not a case 12 
Total 21 
According to Celina WTP personnel, most of the cyanobacteria present in GLSM in June 
2010 was Aphanizomenon. Other cyanobacteria including Microcystis sp. Anabaena sp. and 
Planktothrix sp. co-occured during the summer and early fall. In 2011 Planktothrix sp. returned 
as the dominant organism, as it had been in 2008 and 2009. There are conflicting reports about 
whether Aphanizomenon produces microcystin, however, it is known that strains of Microcystis
sp., Anabaena sp. and Planktothrix sp. do produce microcystin. Microcystin can be toxic to the 
liver and kidneys if ingested (Carmichael et al., 1988). In the summer of 2009, the levels in 
GLSM were recorded as high as 82 parts per billion (ppb). Levels throughout the summer were 
consistently in the 40-60 ppb range. Several other cyanotoxins were also detected including 
cylindrospermopsin, another liver toxin as well as two nerve toxins, saxitoxin and anatoxin-a. 
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Microcystin was the cause for water advisories at GLSM issued in 2009 and 2010. The OEPA in 
conjunction with the ODH and the ODNR have several different advisory levels:  
 “No Contact Advisory”: recommend the public avoid all contact with the water at that 
location. A no contact advisory would be posted if test results show levels at least 20 
parts per billion (ppb) and there has been a report of human illness or pet death. If a no 
contact advisory is posted for a recreational contact area, the State may sample the lake to 
determine if an open water no contact advisory should be posted. Boating and fishing 
would not be impacted by a no contact advisory.  
	 “Public Health Advisory”: posted when tests conclude levels are above six parts per 
billion. At this point, the public would be advised that swimming and wading are not 
recommended, water should not be swallowed and surface scum should be avoided.
	 “Algae Bloom Advisory”: posted for a recreational contact area once an algal bloom has 
been identified and the State has confirmed it is a harmful algal bloom capable of 
producing toxin. The public would be advised not to ingest water and avoid contact with 
surface scum. 
	 “Drinking Water Advisory”: if microcystin, anatoxin-a, cylindrospermopsin, or saxitoxin 
is found above drinking water thresholds in the finished water of a public water system, 
the water system will public notice a drinking water advisory. Depending on the toxin 
level detected, either a do not drink or do not use warning will be issued. The public 
water system may end a public notice when algal toxin levels are below the drinking 
water thresholds in two consecutive samples collected at least 24 hours apart. 
Source: OEPA HAB website http://www.epa.ohio.gov/Default.aspx?tabid=5149 
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Purpose Statement 
The focus of this study was to determine if there was a significant difference in the 
incidence of HCC and CRC in the population served by the Celina WTP. Celina is primarily 
served by the Celina WTP which has used GLSM as source water since 1952. It is estimated that 
25% of the population within the geographic boundaries of Celina is served by small community 
and noncommunity ground water systems and the other75% is served by the Celina WTP 
distribution system. Therefore, it is possible that the population served by the Celina WTP may 
have been exposed to cyanotoxins through drinking water, particularly prior to installation 
(1994) of the dual ozone/peroxide treatment system for controlling taste and odor problems and 
the installation of GAC contactors in 2008. Given the latency of the development of HCC and 
CRC, it is logical to assume that between 1952 when the Celina WTP started using GLSM as 
source water up to and potentially as late as when sampling began in May of 2009 that the 
population of Celina may have been exposed to cyanotoxins from drinking water particularly 
since residents have experienced taste and odor (T&O) problems at the tap. This research sought 
to determine if there was a significant difference in the age adjusted cumulative incidence rate of 
HCC and CRC in the population primarily served by the Celina WTP compared to two GW 
control cities: Wapakoneta and St. Marys.  
Review of Literature 
According to Falconer (2005), the water soluble toxins from cyanobacteria of greatest 
concern to public water systems (PWSs) are the cylindrospermopsins and microcystins. The 
lipid-soluble toxins i.e., anatoxin-a and saxitoxin are typically bound to cells or particulates that 
are easily removed by conventional treatment processes i.e., coagulation, sedimentation and 
filtration (Falconer, 2005). Water-soluble toxins require more specialized treatment processes for 
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removal or inactivation i.e., post clarification treatment by ozone and GAC (Westrick et al., 
2010) which are currently in the treatment process train at the Celina Water Treatment Plant.  
The World Health Organization (WHO) has established a standard for low risk contact at 
<20 µg/L for recreational waters and Ohio adopted that guideline for the 2010 recreational 
season. The WHO also issued a standard for microcystin-LR in drinking water at ≤1 µg/L, 
however there is currently no enforceable Federal or State MCL or maximum contaminant level 
goal (MCLG) for microcystin-LR in drinking water.  
Analytical testing, through October 2011, of the Celina WTP finished water has indicated 
that it is free of cyanotoxins, including microcystin-LR, the most prevalent cyanotoxin at GLSM. 
Microcystin-LR has been demonstrated to be a tumor promoter and there is some evidence to 
show that it may be a factor in liver carcinoma (Fleming et al., 2002; Ohtani, Moore, & 
Runnegar, 1992). A significantly greater risk of HCC was reported (Fleming et al., 2002) within 
the service area of surface water treatment plants in Florida.  
When cyanobacteria produce highly active natural biotoxins, these blue green algal 
blooms are known as a harmful algal blooms (HABs). HABs pose a potentially serious threat to 
human and ecological health as well as creating adverse economic impacts. OEPA has defined 
cyanobacteria blooms as potentially harmful if the cell count exceeds 4000 cells/ml or a visually 
identified concentration discolors the water.  
Not all phytoplankton are cyanobacteria and not all cyanobacteria produce cyanotoxins. 
Therefore, the presence of toxin producing cyanobacteria may not be conclusive; quantitative 
analysis is necessary to determine if cyanotoxins are present (Westrick et al., 2010). Many types 
of cyanobacteria have the potential of producing cyanotoxins, including: Anabaena, Microcystis, 
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Oscillatoria and Planktothrix. Several different cyanotoxins may even be produced 
simultaneously (Falconer, 2005).  
While many varieties of cyanotoxin exist, microcystin, produced by several 
cyanobacterial taxa, is currently believed to be the most common in lakes. Typically, 
cyanobacteria proliferate during the late summer or early fall in eutrophic freshwater ponds, 
lakes, reservoirs, slow moving creeks and in backwaters of rivers (Graham, Loftin, Meyer, & 
Ziegler, 2010). Cyanobacterial blooms can form in marine or freshwaters that are rich in 
nutrients such as fertilizer runoff or septic tank overflows.  
Human Health Impact 
The most extensive review of human health impacts of cyanotoxins was done by U.S. 
Environmental Protection Agency (U.S. EPA) National Center for Environmental Assessment 
(NCEA) (USEPA, 2006). NCEA has prepared the toxicological reviews of cyanobacterial toxins: 
Anatoxin-a, Cylindrospermopsin and Microcystins as a series of dose-response assessments to 
support the health assessment of unregulated contaminants on the Candidate Contaminant List 
(CCL). The purpose of these documents is to compile and evaluate the available data regarding 
toxicity of these toxins to aid the Office of Water in regulatory decision making. Cyanotoxins 
can be classified into three groups based upon the mechanism of specific target organ toxicity: 
hepatotoxins, neurotoxins and dermatotoxins (Graham et al., 2010). Cyanotoxin mixtures are 
important when evaluating human health (Graham et al., 2010). The most noted case study of 
human exposure to cyanotoxins happened in February 1996 in Caruaru, Brazil when 131 people 
were exposed to microcystin-LR through the use of untreated water for dialysis, 116 people were 
sickened and 52 people died (Azevedo et al., 2002).  
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There also have been case reports of severe morbidity and mortality in domestic animals 
through drinking microcystin contaminated water (Fleming et al., 2002). Although there has 
been little epidemiologic research on toxin effects in humans, studies by Yu (1995) and Fleming 
et al. (2002) found an increased association between primary liver cancer in humans and the use 
of microcystin contaminated surface drinking water sources. Falconer (2005) showed that 
exposure to microcystin- LR at sublethal doses is likely to cause continual apoptotic cell death in 
the liver. This process of continuous cell death leads to invasion of the liver by white cells and 
the proliferation of surviving hepatocytes.  
The hypothesis that microcystin is a tumor promoter is based upon the theory of 
multistage carcinogenesis, beginning with mutation and progressing through growth and division
into a tumor (Falconer, 2005). Humpage, Hardy, Moore, Froscio, and Falconer (2000) also 
showed in mice that microcystins could potentially “stimulate” preneoplastic colorectal tumor 
growth. The lining of the colon is likely to be exposed to cyanotoxins from contaminated 
drinking water because unabsorbed toxin will be present in the stomach contents, as well as toxin
being excreted from the liver through the bile (Falconer, 2005). However, there are relatively 
few case reports and even fewer epidemiologic studies of the human health effects of the blue 
green algal toxins (Carmichael & Falconer, 1993; Jalaludin & Smith, 1992; Falconer, 1999; 
Chorus & Bartman, 1999; Fleming et al., 2002).  
Cyanotoxins can have public health implications through a number of different exposure 
routes. Skin exposure may give rise to a rash, hives, or skin blisters (especially on the lips and 
under swimsuits). Inhaling water droplets from irrigation or water-related recreational activities 
can cause runny eyes and nose, a sore throat, asthma-like symptoms, or allergic reactions. 
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Swallowing water that has cyanobacterial toxins in it can cause acute, severe gastroenteritis 
(including diarrhea and vomiting).  
Engaging in recreational activities or inhaling aerosols from water-related activities such 
as jet-skiing or boating is another form of potential exposure. Inhaling aerosols when watering 
lawns, irrigating golf-courses, etc. with pond water contaminated with cyanotoxins has also been 
implicated as an exposure route. Using cyanobacteria-based dietary supplements that are 
contaminated with microcystins also may cause exposure and receiving dialysis with 
contaminated water was documented in Brazil (Azevedo et al., 2002). Drinking water that comes 
from a lake or reservoir contaminated with cyanotoxins or drinking untreated water may result in 
acute and/or chronic sickness.
The lipid soluble natural cyanotoxins: anatoxin-a and saxitoxin are neurotoxins and the 
water soluble cylindrospermopsin and microcystin are hepatotoxins. For the following toxins the 
U.S. EPA Integrated Risk Information System Program has draft studies for setting guidance 
levels. The below web links are where that study is located:
Microcystin: http://cfpub.epa.gov/ncea/iris_drafts/recordisplay.cfm?deid=160548 
Anatoxin-a: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=160546 
Cylindrospermopsin: http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=160547 
Anatoxin-a 
Anatoxin-a is also known as “very fast death factor”. It has a mode of action through the 
nicotinic receptors where it acts as an analogue of acetylcholine. However, the molecule is not 
degraded by cholinesterase, thus causing permanent stimulation of muscle cells leading to 
paralysis. Paralysis leads to dyspnea, cyanosis and cardiac arrhythmia, leading to death. 
Anatoxin-a also can bind to presynaptic nicotinic receptors to trigger neurotransmitter release.  
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Cylindrospermopsin 
The toxic alkaloid cylindrospermopsin is a potent inhibitor of protein synthesis with the 
liver as the main target. It was first isolated from Cylindrospermopsis raciborskii from a water 
supply reservoir on Palm Island off the coast of Queensland Australia (Ohtani et al., 1992). 
Studies have shown four consecutive phases of the pathological changes in the liver: 1) protein 
synthesis inhibition, 2) membrane proliferation, 3) fat droplet accumulation, and 4) cell death. 
Cylindrospermopsin exposure has also led to a decrease in the content of reduced glutathione 
(GSH) in rat hepatocytes (U.S. Environmental Protection Agency [U.S. EPA], 2006). The 
reduction in GSH induced by cylindrospermopsin was attributed to the inhibition of GSH 
synthesis. The nucleotide structure of cylindrospermopsin and the presence of potentially 
reactive guanidine and sulfate groups suggest that the toxin may also exert its effect through an 
interaction with DNA or RNA. Covalent binding of cylindrospermopsin or its metabolites to 
DNA has been reported in treated mice with accompanying significant DNA strand breakage 
(U.S. EPA, 2006). 
Saxitoxin
Saxitoxin was named after the mollusk Saxidomus giganteus from which was first recognized 
the paralysis characteristic of saxitoxin poisoning. It is lipid soluble and readily absorbed from
the gastrointestinal and respiratory tract. It is a potent neuroparalytic agent that binds to the 
sodium channels of nerve and muscle tissue, preventing propagation of action potentials in 
excitable cells and, ultimately, causing blockade of depolarization at the neuromuscular junction. 
Saxitoxin poisoning can ultimately lead to neuromuscular dysfunction, the most serious of which 
is respiratory paralysis that, in severe cases, may result in death from respiratory failure.  
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Microcystins 
In 2006 the International Agency for Research on Cancer (IARC) reviewed current 
evidence for carcinogenic potential of microcystin-LR. Members of the IARC Working Group 
reached the following consensus during its review: 
 There is inadequate evidence in humans for the carcinogenicity of microcystin-LR. 
 There is inadequate evidence in experimental animals for the carcinogenicity of 
microcystin-LR. 
 There is strong evidence of mechanistic data for the carcinogenicity of microcystin-LR.  
 Microcystin-LR was therefore classified to group 2B, indicating that it is possibly
carcinogenic to humans. 
Source: http://oncology.thelancet.com Vol. 7 August 2006  
Microcystin has been isolated from multiple genera of cyanobacteria including 
Planktothrix, Oscillatoria, Anabaena, Microcystis, Chroococcus, and Nostoc (Pearson et al., 
2010). The microcystins are the largest and most structurally diverse group of cyanotoxins. 
There are currently around 90 different microcystin- isoforms according to Pearson, Mihali, 
Moffitt, Kellmann, and Neilan (2010).  
The peptide ring is made up of a total of seven amino acids including two protein amino 
acids and five nonprotein amino acids. It is the two protein amino acids that distinguish 
microcystin types from each other, while the other amino acids are relatively constant. By using 
amino acid single letter code classification, each microcystin isoform is designated a name
depending on the variable amino acids which complete their structure. For instance, one of the 
most common toxins found in water supplies around the world, microcystin-LR contains the 
amino acids Leucine (L) and Arginine (R) in these variable positions. Each of the isoforms have 
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been reported to have varying toxicity levels. The LD50 of the most common isoform, 
microcystin-LR, is 50 µg/kg of body weight, while microcystin-RR is 600 µg according to 
Westrick, Szlag, Southwell, and Sinclair (2010). LD50 is the lethal dose to 50% of the 
population. 
Most of our understanding about the toxicity of microcystins is based upon studies with 
mice that received intraperitoneal injections of microcystin-LR. In these studies, the injection of 
microcystins cause death within a few hours. Early manifestations of liver damage include an 
increase in serum of liver enzymes: a sign of liver cell death, and increased liver weight 
(Falconer, 2005). 
Microcystins inhibit a class of enzymes known as protein phosphatases. These enzymes 
remove phosphate from a protein, a common step in many biochemical pathways. This 
inhibition, with subsequent buildup of phosphorylated proteins, is believed to be a mechanism by 
which microcystins destroy liver cells. These hepatotoxins inhibit the protein phosphatases inside 
hepatocytes. Hepatotoxins damage the liver by affecting cytoskeleton maintenance, disrupting 
the balance of phosphate groups on cytoskeletal proteins. The hepatotoxins cause the hepatocytes 
to collapse inwards collapsing the cytoskeleton. The hepatocytes and also the capillary cells then 
pull apart, spilling blood into the liver. The blood pools in the liver, causing death according to 
Falconer (1999). 
The WHO conducted an evaluation of the Tolerable Daily Intake (TDI) level for 
microcystin-LR, based on a noncancer endpoint. The TDI is the maximum daily dose of 
microcystins that is considered safe. This value, 0.04 µg per kg body weight per day (μg/kg/day), 
is based on the results of liver toxicity studies in mice observed in a 13-week study and applying 
an uncertainty factor of 1000 and taking into consideration limitations in the database, in 
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particular lack of data on chronic toxicity and carcinogenicity. Generally, the TDI is an estimate 
of the amount of a substance in food and drinking-water, expressed on a body weight basis 
(mg/kg or mg/kg of body weight), that can be ingested over a lifetime without appreciable health 
risk.
The TDI is calculated based on either a no-observable-adverse-effect level (NOAEL) or 
lowest-observed-adverse-effect level (LOAEL) divided by an uncertainty factor (UF) TDI = 
(NOAEL or LOAEL) ÷ UF.
Using this TDI, the WHO also developed a drinking water concentration limit of 1.5 
μg/L for microcystin-LR. The WHO assumed that a 60 kg (132 lbs) person drinks two liters of 
water each day and that 80% of the two liters is from a contaminated source. Their calculation 
was as follows: 
0.04 μg microcystin/kg body weight/day x 60 kg person ÷ (2 L water/day x 0.80) = 1.5 μg/L 
The guideline value (GV) is then derived from the TDI as follows GV = (TDI × bw × P) ÷ C. 
where: 
 bw = body weight 
 P = fraction of the TDI allocated to drinking-water 
 C = daily drinking-water consumption 
A guideline value (GV) was set at 1 μg/L (for total microcystin-LR, free plus cell-bound) 
and has been adopted by the State of Ohio. The GV is provisional, as it covers only 
microcystin-LR, the database is limited and new data for the toxicity of cyanobacterial toxins are 
being generated and expected in 2011. The WHO also categorized swimming risk levels as mild, 
moderate, high, or very high based on the water concentration of microcystins. These water 
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concentrations are related to whether a swimmer, weighing 60 kg and ingesting 100 ml of water, 
would exceed the TDI (World Health Organization [WHO], 2003). 
Regulatory Status 
The 1996 Safe Drinking Water Act (SDWA) requires U.S. EPA to develop a list of 
contaminants that are known or anticipated to occur in drinking water and to publish the list 
every five years. U.S. EPA must then decide whether or not to regulate at least five contaminants 
with a NPDWR after evaluating criteria specified under the 1996 SDWA, and then publish 
determinations on a five-year cycle. Specific criteria considered by the U.S. EPA for regulatory 
determination include the following: 1) Does the contaminant have an adverse effect on humans, 
2) Does the contaminant occur in PWSs at a frequency and level of concern, and 3) Is there a 
meaningful opportunity for health risk reduction for persons served by a PWS.  
The most current regulatory determination cycle (Reg. Det. 3) and the associated third
candidate contaminant list (CCL3) are described in the federal register notice (74 FR 51850). 
The CCL3 is a list of 116 unregulated contaminants used by the U.S. EPA to prioritize data 
collection to decide if a regulatory determination is required. Three cyanotoxins were included 
on CCL3: microcystin, cylindrospermopsin, and anatoxin-a. However, based upon information 
from a recent public stakeholder meeting sponsored by the U.S. EPA held June 16, 2011, 
cyanotoxins were not included on the short list of 32 contaminants being considered for 
regulation during the regulatory determination 3 cycle which is due July 2013. U.S. EPA 
indicated in their decision not to pursue a regulatory determination on cyanotoxins for which 
there is no national occurrence survey and inadequate health effects data.  
Potency, severity, prevalence, and magnitude, are key decision criteria used by the U.S. 
EPA in evaluating chemical contaminants for NPDWRs. Cyanotoxins are some of the most 
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potent toxins known to man. The 1998 CCL included cyanobacteria and their toxins as one of the 
microbial contaminants selected, but it did not specify which toxins should be targeted for study. 
With over 80 variants of cyanotoxins now being reported, the scientists from the U.S. EPA 
Office of Ground Water and Drinking Water have to review new toxicological, epidemiological 
and occurrence studies before determinations can be made. All of the three CCL3 cyanotoxins 
have been detected at GLSM in northwestern Ohio. Fortunately, the Celina WTP has processes 
in place to mitigate cyanotoxin contamination of finished drinking water. There are no standards 
in the U.S., however there are standards in several other countries and the WHO standard of 1 
µg/L. The following Table 2 lists current international standards for cyanotoxins:  
Table 2 
Guidelines for Cyanotoxin contamination in Drinking Water 
Cyanotoxin Guideline 
U.S.: No official guideline 
Australia: 3 μg/L (suggested) 
Saxitoxin	 U.S.: No official guideline 

Australia: 3 μg/L (suggested) 

U.S.: No official guideline 

World Health Organization: 1 μg/L
 
Brazil: 1 μg/L (Regulatory Level) 

Australia: 10 μg/L or 1.3 μg/L 

New Zealand: 1 μg/L
 
Canada: 1.5 μg/L 

Cylindrospermopsin 	 U.S.: No official guideline 

World Health Organization: 1 μg/L
 
Water Treatment 
Removal of cyanobacteria from GLSM likely will require multiple specialized treatment 
technologies. The best approach is to decrease the external loading of phosphorous and nitrogen 
laden silt into the lake which would create a more diverse ecosystem. The source of these 
nutrients is the result of agricultural operations, wastewater plant effluents, septic tank overflows 
and erosion. By reducing the nutrients, (primarily phosphorous) from entering the lake, the 
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cyanobacteria blooms could be reduced or eliminated reducing or eliminating potential adverse 
public health impact from cyanotoxins through either recreating in the lake or from exposure to 
contaminated drinking water. There are two overarching approaches to treatment: 1) mitigate the 
cyanobacteria in the source water and 2) removal of cyanotoxins in the drinking water treatment 
process. 
Source Water Treatment 
The action plan being implemented by the State of Ohio includes both internal and 
external phosphorous control. One treatment technology involves the use of alum (aluminum 
sulfate) application to several test demonstration sites within the lake. Theoretically, alum will 
bind dissolved phosphorus which will then precipitate out making it unavailable as a nutrient for 
cyanobacterial metabolism. The process involves spraying liquid alum on selected areas in 
precise dosages. 
Correct dosage is key to effective use of alum in any treatment process. This is for 
several reasons including formation of the hydronium ion that will increase acidity. A buffer 
must therefore be added to mitigate harmful unintended consequences to the aquatic ecosystem.
The alum (AL+3) will bind organic carbon forming aluminum phosphate (ALPO4) in the sludge 
of the hypolimnion. Also, alum has a point of diminishing return dependent on pH, temperature, 
and most importantly natural organic demand measured as total organic carbon (TOC). The TOC 
measured in mg/L of the water will have a demand on the alum concentration i.e., much of the 
alum will bind to organic carbon in addition to phosphorous. TOC concentration can have 
significant seasonal variation and fluctuates between 9.0 – 14.0 mg/L in GLSM. Typically, alum
would be used under very controlled conditions in a water treatment plant. Potentially, if the 
alum is shown to be effective, it would be used throughout the entire lake to prevent a HAB the 
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following year and potentially for several years thereafter. The thought is if this treatment is 
effective in removing total phosphorous over the short term, it would allow more time for 
projects involving external loading to impact the proliferation of HABs. The OEPA-funded 
project began the week of September 20, 2010 and totaled nearly 53 acres. The action plan also 
recommended a small scale pilot demonstration project covering the bottom silt with silica sand 
with the intent of making water quality conditions less favorable to cyanobacteria and more 
favorable for nontoxic green algae with a greater diversity of phytoplankton.  
According to the OEPA, the external loading issues can be improved through education 
and public outreach including fertilizer handling best management practices e.g., manure 
hauling, fertilizer coverage, changes in animal feed, limiting the use and type of lawn treatment 
and proper oversight and inspection of septic systems. Action items also include better oversight 
which would limit phosphorus discharges from wastewater treatment plants within the GLSM 
watershed. The ODNR is pushing for regulatory actions to prohibit fertilizer application during 
the winter and a requirement for farmers to develop a nutrient management plan if they handle 
more than 350 tons of manure annually. 
According to the GLSM Lake Restoration Organization, several other interesting projects 
are underway including installation of embankments to mitigate the silt from nine tributaries 
from entering the lake. The current project involves installation of equipment at Prairie Creek. 
Another project involves installation of two aeration systems known as Airy-Gators which are 
mobile and will oxygenate specific areas of the lake. Ultimately, the plan would involve some
13-14 of these units at various locations around the lake, at a cost of about $30,000 each.  
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Drinking Water Treatment 
According to Westrick et al. (2010), the most important factor for the removal/ 
inactivation of cyanotoxins from water is whether they are intracellular or extracellular.
Cyanotoxins can exist as internally bound toxins, for example microcystin bound to protein 
phosphatases, enclosed within the cell membrane, or externally released toxins when released 
into water as a result of cell lysis, excretion or active transport. The hydrophilicity, 
hydrophobicity, molecular size, and functional groups of the specific cyanotoxins affect the 
efficiency of the treatment process (Westrick et al., 2010). Generally a treatment approach that 
removes intact cells i.e., does not lyse the cells releasing cyanotoxin into the water is the most 
efficient treatment approach (Westrick et al., 2010). Ozonation of intact cells can release 
cyanotoxins as well as taste and odor producing compounds into the water (Westrick et al., 
2010). Treatment options to remove specific cyanobacteria and toxins are found in table 3. 
 Enhanced Coagulation 
 Ballasted Flocculation
 Conventional Treatment (Coagulation/Sedimentation) 
 Slow Sand Filtration* 
 Granular Activated Carbon (GAC)* 
 Biologically Activated Carbon (BAC)* 
 Filtration*
 Microfiltration* 
 Nonchlorine Oxidants* 
*Note. These processes are more effective after coagulation/sedimentation processes
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Table 3 
Treatment Options for Specific Toxins
Cyanotoxin 	Drinking Water Treatment Option 
Carbon (PAC, GAC) (adsorption) 
Ozone (anatoxin-a) 
Chlorine (anatoxin-a(s) 
Saxitoxin: 	 Carbon (PAC, GAC) 
Boiling
Ozone 
Chlorine (less effective)
Filtration
Carbon (PAC, GAC) 
Chlorine 
Ozone 
Microcystin: 	 Chlorine 
Filtration
Ozone 
Carbon (PAC, GAC) 
Chlorine 
Filtration
Ozone 
Carbon (PAC, GAC) 
Notes. Adapted from U.S. EPA Office of Ground Water and Drinking Water 
PAC = powdered activated carbon 
Research Questions
This study is a comparison of the proportion of HCC and CRC cases in the population 
primarily served by the Celina WTP with the populations of the control cities of Saint Marys and 
Wapakoneta as well as the populations of Mercer and Auglaize Counties. The measure of 
comparison for this research is the cumulative incidence rate and the cumulative age adjusted 
incidence rate.  
The research hypotheses are: 
Q1: Is there an association between possible exposure to cyanotoxins from drinking 
water and the incidence of CRC in the population primarily served by the Celina WTP? 
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Q2: Is there an association between possible exposure to cyanotoxins from drinking 
water and the incidence of HCC in the population primarily served by the Celina WTP”? 
Research Methods
This was an observational study to compare the cumulative age adjusted incidence rates 
(IR) of HCC and CRC in the population served primarily by the Celina WTP (surface water) 
with cities of Saint Marys and Wapakoneta (ground water).  
Statistical Analyses 
A “case” was defined as a person diagnosed with CRC or HCC while a resident of the 
cities of Celina, Wapakoneta or Saint Marys, in Ohio. Cases were identified through the Ohio 
Cancer Incident Surveillance System, Ohio’s central cancer registry. Cases diagnosed that were 
reported to the OCISS were included in the analysis for all years for which data were available 
(1996-2008). The estimated 95% CI for the CRC and HCC comparison for the age adjusted 
cumulative incidence rates were compared to SEER’S and Ohio’s rates. The Chi-squared test 
was performed to calculate HCC and CRC IR differences. 
Wapakoneta and Saint Marys, two neighboring cities to Celina were chosen as controls 
from populations served by ground water. The assumption was that ground water is much less 
likely to be contaminated by cyanotoxins than surface water. Data also were extracted for Mercer 
and Auglaize Counties to compare cancer IR between counties (Celina is in Mercer County 
[Federal Information Processing Code (FIPS) code 107]) and Saint Marys is in Auglaize County 
on the Western end of GLSM (FIPS code 011). Wapakoneta situated east of GLSM is also in 
Auglaize County and is of similar size and demographics to Celina (Appendix C for locations).  
Celina cases were identified as the “observed” cases. These Wapakoneta and Saint Marys 
cases were identified as the “observed control” cases. All cases were mapped by address using 
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GIS at diagnosis to accurately identify residents as defined by the U.S. Census Bureau. Cancer 
cases are reported to the OCISS by all laboratories, hospitals, radiation treatment centers, and 
ambulatory surgical centers in the state of Ohio. These data are subjected to verification and 
validation procedures before entry into the OCISS database. The International Classification of 
Diseases for Oncology, 3rd edition (ICD-O-3), was used for coding the topology and morphology 
of tumors. The data set analyzed in this research was extracted using standard query language 
queries of the OCISS SQL Server database. Data included the following: age at diagnosis, 
county, city, address, and zip code at diagnosis, cancer type i.e., colon and rectum (Colorectal, 
CRC) or liver and intrahepatic bile duct (hepatocellular, HCC), residence address, and diagnosis 
date. The human subjects proposal was approved by the Institutional Review Boards from the 
graduate school of Wright State University (SC# 4531, approved July 7, 2011 and the Ohio 
Department of Health [ODH] IRB00002180, protocol 2011-15, approved July 26, 2011).  
Data were extracted using Surveillance Epidemiology and End Results Codes. For the 
operational definition of case of liver and intrahepatic bile duct (HCC cases) was all records with 
the following ICD-O-3 diagnostic codes: code 8170/3, 8171/3, and 8180/3. The operational 
definition for “case of Colorectal cancer” was all records with the following ICD-O-3 codes for 
Colorectal cancer ICD-O-3: code 19.9 through 21.8. The histology codes for CRC and HCC are 
listed in the following Table 4: 
Table 4 
Histology Codes used for Colorectal Cancer (CRC) and Hepatocellular Carcinoma (HCC) 
Colorectal Cancer 8140-8147, 8160-8162, 8180-8221, 8250-8506, 8520-8550, 
8560,8570-8573, 8940-8941 
Hepatocellular Carcinoma  8170/3, 8171/3, and 8180/3 
Note. Adapted from International Classification of Diseases for Oncology, 3rd edition (ICD-O-3). 
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GIS Methods 
Using Arc GIS®, a map was generated for the census geographic place boundaries of
each city. The raw data relative to HCC cases and CRC cases from diagnosis years 1996 2008 
were retrieved from the OCISS. Residence addresses from the OCISS data were geocoded using 
ARCGis version 10.0 U.S. address locator file. Geocoding addresses permits identification of 
cases and controls based on the physical location of the place of residence at the time of 
diagnosis. Residences outside of city (place) boundaries may use the city name in addresses. 
Geocoding is a more accurate method to identify location than using the “city” name provided in 
the residence address. Only residences inside place (city) boundaries are identified as being in 
the city. The HCC and CRC cases from 1996 2008 were spatially joined to the geographic 
boundaries of the city. The cases were mapped and overlaid with the geographic boundaries of 
the city of Celina, Saint Marys and Wapakoneta. This approach was taken to facilitate 
comparison with a previous study entitled: Cancer Incidence among Residents of Avon Lake, 
Lorain County Ohio (1996 2006), (Ohio Department of Health [ODH], 2009).  
Population Estimates 
To calculate the age adjusted cumulative incidence of HCC and CRC in the study 
populations, estimates of the cumulative populations were determined for Mercer and Auglaize 
County using the intercensal estimates for 1996-2000, bridged estimates for 2000 (U.S. Census 
Data) and vinatage post censal estimates for 2001-2008. The cumulative population estimates for 
period 1996-2008 for the cities of Celina (123,636), Saint Marys (100,104) and Wapakoneta 
(113,688) were estimated as a proportion of the relevant county estimate. The cumulative 
population of Celina was estimated based upon the proportion of the Mercer county population 
from the 2000 census (40,908 persons). The populations of Wapakoneta and Saint Marys were 
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estimated based upon the proportion of the population of Mercer County (46,589) from the 2000 
census. The cumulative population estimates for all cities and the Ohio counties of Mercer and 
Auglaize and the state of Ohio are given in Table 5 below: 
Table 5 
Cumulative Population Estimates (1996-2008) 
Place Cumulative Population (1996-2008)
Mercer County 530,675 
Celina 133,847 
Auglaize County 605,242 
Wapakoneta 123,078 
Saint Marys 108,372 
Ohio 148,081,069 
Note. Adapted from U.S. Census Bureau.
Age adjustment is a statistical process applied to rates of disease, death, injuries or other 
health outcomes that allows communities with different age structures to be compared. Specific 
rates for each age group were calculated, then weighted and summed to obtain an age adjusted 
incidence rate. These data were then used to calculate the age adjusted cumulative incidence for 
both HCC and CRC. Age-adjusted incidence rates are calculated using the direct method of age-
adjustment (Hoyert & Anderson, 2001). This involves weighting age-specific incidence rates by 
a standard set of weights based on the 2000 standard million (Appendix A). The weights 
represent the proportion by age in a standard population using the 2000 population beginning 
with data year 1999 (Anderson & Rosenberg, 1998). Results were expressed as age-standardized 
incidence rates using the 2000 US standard million population and Ohio population estimations. 
Age-adjusted incidence rates were calculated based upon the weighting by number of cases in 
each of the 2000 Census age groups. 
Cumulative age adjusted incidence rates (IR) for hepatocellular (HCC) and colorectal 
cancer (CRC) were calculated. The cumulative IR, and 95% confidence interval (95% CI) of 
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CRC and HCC was also compared between Mercer and Auglaize counties. The number of 
cancer cases between cities and counties were compared using chi-square. 
Comparison with Ohio and SEER Data 
As of 2000, SEER collects and publishes cancer incidence data from 17 population-based 
registries covering 26% of the U.S. population. Prior to 2000, SEER collected data for a smaller 
region consisting of 13 registries (SEER 13). Data were available from the SEER 13 region for 
the entire 1996-2006 study period; thus, the SEER 13 region was selected for comparison. Rates 
for the white population were used to most closely correspond to the racial composition of 
Celina, Wapakoneta and Saint Marys. The observed and expected IRs were compared for both 
HCC and CRC to Ohio and SEER data. The Standardized Incidence Ratio (SIR) was used to 
compare the observed and expected numbers of cases, where: 
SIR = Observed cases / Expected cases
A SIR greater than one indicates more observed cases than expected, and a SIR less than one 
indicates fewer observed cases than expected. Significance of the SIR was determined by 
calculating 95 percent confidence intervals (CI) based on the Poisson distribution using Fisher’s 
Exact Test. If the confidence interval for a given SIR did not include 1.0, the difference between 
the observed and expected numbers was determined to be statistically significant (p<0.05). 
Results and Data Analysis 
From the OCISS crude data, the city of Celina had a total of 8 cases of HCC and 175 
cases of CRC over the period (1996-2008). The GW control populations for the city of 
Wapakoneta had 9 cases of HCC and 167 cases of CRC while Saint Marys on the eastern end of 
GLSM had slightly fewer cases of HCC (6 cases) and 112 cases of CRC. All of the study 
populations demonstrated a higher incidence for CRC cases than HCC cases. These data would 
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indicate that HCC is more rare than CRC in these study populations. Case counts for the state of 
Ohio, as well as Mercer and Auglaize counties also demonstrated a similar trend. The following 
Table 6 lists the crude case counts for HCC and CRC from the OCISS database 1996-2008: 
Table 6 
Crude Case Counts for HCC) and CRC (OCISS Database) (1996-2008) 
Place HCC CRC Total
Mercer 17 365 382 
Celina 8 175 183 
Auglaize 21 402 423 
Wapakoneta 9 167 176 
Saint Marys 6 112 119 
Ohio 6693 84,846 91539 
The geocoded data case counts were less than the OCISS raw data case counts for all city 
populations. Celina had three cases of HCC and 105 cases of CRC within the geographic 
boundaries of the city compared to the non-geocoded OCISS data of eight HCC cases and 175 
CRC cases. Wapakoneta and St. Marys had three and four cases of HCC respectively and 102 
and 71 cases of CRC. The geocoded data were used to calculate the cumulative age adjusted 
incidence rates for all city populations in the study. The following (Table 7) includes the 
geocoded case counts for HCC and CRC for the three cities in the study. 
Table 7 
Geocoded Case Counts for HCC and CRC (OCISS Database) (1996-2008) within the City 
Geographic Boundaries 
HCC CRC Total
Celina 3 105 108 
Wapakoneta 6 102 108 
St. Marys 4 71 75 
Cumulative Incidence 
Cumulative Incidence Rates (IR) were calculated for all study populations including 
cities, counties and Ohio. Celina had the lowest cumulative IR for HCC (2.2/100,000) compared 
to Wapakoneta (4.9/100,000) and Saint Marys (3.7/100,000). The HCC IR for Celina was less 
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than the associated Mercer County rate 3.2/100,000 and the Ohio rate of 4.5/100,000. Both 
control cities: Wapakoneta and St. Marys however had higher IRs for HCC than the associated 
Auglaize county rate 3.2/100,000. 
The rates for CRC followed a very different trend than the HCC rates. The Celina CRC 
rate was 78.4/100,000 which was lower than Wapakoneta 82.9/100,000, but higher than Saint 
Marys 65.5/100,000. Celina’s IR was higher than the corresponding county rate of Mercer 
68.8/100,000. Wapakoneta also had a higher CRC IR 82.9/100,000 compared to Auglaize 
County 66.4/100,000. All of the city’s IRs for CRC were higher than the Ohio IR of 57.3. The 
HCC and CRC IRs for all study populations are summarized in (Table 8) below:  
Table 8 
Cumulative Incidence Rates per 100,000 for HCC and CRC (OCISS Database) (1996-2008)
within the City Geographic Boundaries 
Place HCC CRC Total
Mercer County 3.2 68.8 72.0 
Celina 2.2 78.4 80.7 
Auglaize County 3.2 66.4 69.9 
Wapakoneta 4.9 82.9 87.7 
Saint Marys 3.7 65.5 69.2 
Ohio 4.5 57.3 61.8 
The cumulative IRs/100,000 were adjusted for age. The age adjustment factors used for 
each age group in Mercer and Auglaize counties are found in Appendix A-7. The age adjusted 
cumulative IR for HCC (Table 9) for Celina of 2.1/100,000 was lower than all other cities. 
However, the age adjusted cumulative IR for CRC in Celina was higher (69.4/100,000) than 
Saint Marys (57.5/100,000) but lower than the other ground water control Wapakoneta 
(73.4/100,000). The CRC rates for the cities of Celina and Wapakoneta, 69.4/100,000 and 
73.4/100,000 respectively were higher than the associated county rates of Mercer and Auglaize 
counties, 61.3/100,000 and 57.6/100,000 respectively. All city and associated county rates for 
CRC were higher than the Ohio rate of 53.9/100,000. The HCC rates were lower than the Ohio 
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rate of 4.2/100,000 for all populations except for Wapakoneta which was only slightly higher 
4.4/100,000. The age adjusted cumulative IRs for HCC and CRC in all study populations are 
summarized in Table 9. 
Table 9 
Age Adjusted Cumulative for HCC and CRC (OCISS Database) (1996-2008) within the City 
Geographic Boundaries per 100,000 
Place	 HCC CRC Total
Mercer County 2.9 61.3 64.2 
Celina 2.1 69.4 71.5 
Auglaize County 3.0 57.6 60.6 
Wapakoneta 4.4 73.4 77.8 
Saint Marys 3.3 57.5 60.8 
Ohio	 4.2 53.9 58.1 
The CRC IRs/100,000 for Celina, Wapakoneta and St. Marys were 69.4, 73.4 and 
57.5/100,000 respectively. The HCC IRs/100,000 were 2.1, 4.4 and 3.3/100,000 respectively. 
The CRC IRs for Celina and Wapakoneta were higher than the Ohio and U.S. SEER rates. The 
HCC IRs for Celina and St. Marys were lower than Ohio and U.S. (SEER) rates. The Celina, 
Wapakoneta and St. Marys IRs for CRC and HCC as well as Ohio, and U.S. (SEER) rates are 
found in Table 10 below.
Table 10 
Number of CRC and HCC Cases in Celina, Ohio and Age Adjusted Cumulative Incidence Rates 
per 100,000 for HCC and CRC within the City Geographic Boundaries with comparison to Ohio, 
and the U.S. (SEER) 1996-2008 
HCC CRC	 Total 

cases
 
Celina 2.1 69.4 71.5 
Wapakoneta 4.4 73.4 77.8 
St Marys 3.3 57.5 60.8 
Ohio* 4.0 54.8 --
U.S. (SEER) 5.2 50.6 --
* 
*1996-2006 
The SIR was calculated from the observed IR for each city divided by the expected Ohio 
rates. The 95% CI of CRC and HCC IRs was compared with the observed IRs in Ohio 
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4.0/100,000 and 54.8/100,000 for HCC and CRC respectively. The HCC SIR for Celina = 0.53, 
Wapakoneta = 1.10 and St. Marys = 0.83. Wapakoneta was the only city with an HCC SIR > 1.0 
indicating the observed rate 4.4/100,000 was greater than the expected Ohio rate 4.0/100,000. 
The CRC SIRs for Celina, Wapakoneta and St. Marys were all > 1.0 indicating the observed 
rates were higher than expected based upon comparison to Ohio. In fact, the CRC IR for Celina 
and Wapakoneta were 27% and 33% higher than the Ohio rate, respectively (P <0.05). The CRC 
rate in St. Marys 57.7/100,000 was not significantly different than the Ohio Rate 54.8/100,000 (P 
> 0.05). The SIR comparison of IRs for each city (observed) compared to the (expected) rates for 
the state of Ohio are found in Table 11 below. 
Table 11 
Observed (O) and Expected (E) number of HCC and CRC Cases in Celina, Ohio and 
Standardized Incidence Ratios (SIR) and 95% Confidence Intervals (95% CIs) 1996-2008 
comparison with Ohio rates
HCC CRC
O E SIR (95% CI) p-value† O E SIR (95% CI) p-value† 
Celina 2.1 4.0 0.53 (0.27, 1.39) 0.342 69.4 54.8 1.27 (1.01, 1.57) 0.049 
Wapakoneta 4.4 4.0 1.10 (0.55, 2.19) 0.841 73.4 54.8 1.33 (1.08, 1.65) 0.012 
St Marys 3.3 4.0 0.83(0.40, 1.81) 0.726 57.5 54.8 1.05 (0.82, 1.33) 0.715 
Ohio* 4.0 -- -- -- 54.8 -- --- --
*1996-2006 
†Chi-Sq p-value 
A similar analysis was performed to compare the city rates to the U.S. SEER rates. The 
SIR was calculated from the observed IR for each city divided by the expected SEER rates for 
both HCC and CRC. The CRC IR for Celina and Wapakoneta 69.4/100,000 and 73.4/100,000 
respectively were significantly higher than the U.S. SEER rate 50.6/100,000 (P< 0.05). In fact 
Celina was 37% higher and Wapakoneta was 45% higher. The HCC IRs for all cities were not 
significantly different than the U.S. SEER rate 5.2/100,000 (P>0.05). The SIR comparison of IRs 
for each city (observed) compared to the (expected) rates for the U.S. SEER rates are found in 
Table 12.
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Table 12 
Observed (O) and Expected (E) number of CRC and HCC Cases in Celina, Ohio and 
Standardized Incidence Ratios (SIR) and 95% Confidence Intervals (95% CIs) 1996-2008 
comparison with U.S. (SEER) rates
HCC CRC
O E SIR (95% CI) p- O E SIR (95% 
CI) 
p-
value† value† 
Celina 2.1 5.2 0.40 (0.21, 1.07) 0.174 69.4 50.6 1.37 0.008 
(1.10, 1.70) 
Wapakoneta 4.4 5.2 0.84 (0.42, 1.69) 0.726 73.4 50.6 1.45 0.001 
(1.17, 1.79) 
St Marys 3.3 5.2 0.63 (0.31, 1.39) 0.405 57.5 50.6 1.14 0.332 
(0.89, 1.44) 
U.S. (SEER)* 5.2 -- -- -- 50.6 -- -- --
*1996-2006 
†Chi-Sq p-value 
The following (Figure 3) is a visual trend analysis histogram plot of the age adjusted 
cumulative incidence rates of HCC for the City of Celina compared to St. Marys, Wapakoneta, 
Mercer and Auglaize Counties as well as the state of Ohio.  
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Figure 3. Age Adjusted Cumulative IR for HCC/100,000.  
The following (Figure 4) is a visual trend analysis histogram plot of the age adjusted 
cumulative incidence rates of CRC for the City of Celina compared to St. Marys, Wapakoneta, 
Mercer and Auglaize Counties as well as the state of Ohio.  
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Age Adjusted CRC Rate/100,000 
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Figure 4. Age adjusted Cumulative IR for CRC /100,000 
Discussion
The results of this study were inconclusive to support that cyanotoxins from GLSM are 
associated with excess risk of cancer from exposure to contaminated drinking water. The CRC 
IRs in Celina, St. Marys and Wapakoneta were however significantly higher than Ohio and 
national SEER rates. This finding suggests chronic human health effects associated with the 
areas close to surface waters contaminated by cyanotoxins merits further investigation. Data 
were interpreted in light of lack of specific individual exposure data, latency of the formation of 
cancer from low level exposure to drinking water, population mobility and potential 
confounders. 
The ground water controls in this study: Wapakoneta and St.Marys are both located 
within the watersheds of eutrophic lakes i.e. Indian Lake and Grand Lake Saint Marys. More 
study is needed to evaluate the HCC and CRC IRs within the entire GLSM region and around 
other contaminated surface waters throughout the state. There is a critical gap in human health 
effects data associated with low level exposure to cyanotoxins in drinking water. Considering the 
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latency of cancer, it will be of research interest to associate cyanotoxin exposure with short term
health outcomes such as acute gastrointerititis, respiratory tract effects or skin manifestations.  
Some of the strengths of this study were that we used state based data (OCISS). This is 
one of the few studies that had explored the human health impact of HABs. The OCISS database 
is a very a powerful tool for researchers to study cancer clusters in specific areas. We used a 
population based research design, contrasted the exposed versus the control cities, and utilized 
national SEER rates for comparison. We also used GIS to geocode all addresses giving more 
accurate case counts specific to the city populations. However there are some weaknesses that 
need to be mentioned. We did not have individual level data, and were not certain about the long 
term exposure status of the participants. We were also limited by the cross sectional design of the 
study and could not determine the cause and effect association. The only health outcome data 
available to us was HCC and CRC cancer, which could have a multifactorial etiology including 
pesticide exposure, dietary intake pattern or potentially recreational exposure. Clearly more work 
is needed to determine association of short term health endpoints with cyanotoxins.  
There are no current NPDWRs for cyanotoxins therefore it is important for public water 
systems to be vigilant in monitoring and treating cyanotoxins in contaminated source waters 
based upon acute effects alone. The problem of HABs is world-wide and of significant concern 
in Ohio, therefore the treatment technologies being demonstrated at GLSM for internal reduction 
of nutrient enrichment as well as the nutrient management best practices for decreasing external 
loading could become a model for long-term effective control of HABs in Ohio. The threats of 
the HABs at GLSM are multifaceted and so will be the solutions. The epidemiological approach 
used in this study could be applied to other regulated and emerging drinking water contaminants. 
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Most importantly, these data will provide a baseline for future studies to evaluate changes in 
cancer rates at Grand Lake Saint Marys.  
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APPENDICES
Appendix A. United States standard year 2000 population: Numbers and proportions 
(weights) 
Age Range (years) Number Weight 
<1 13,818 0.013818 
1-4 55,317 0.055317 
5-14 145,565 0.145565 
15-24 138,646 0.138646 
25-34 135,573 0.135573 
35-44 162,613 0.162613 
45-54 134,834 0.134834 
55-64 87,247 0.087247 
65-74 66,037 0.066037 
75-84 44,842 0.044842 
85≤ 15,508 0.015508 
Source: National Vital Statistics Reports, Vol. 49, No. 9 (9/21/01) 
Table A-1. Hepatocellular Carcinoma (HCC)—Celina (Age Adjusted Rates) per 100,000 
Age HCC Population Rate per 100,000 Weight (d) Weighted 
group Number of (thousands) (c = [a ÷ b] × 100,000) Rate (c × d) 
(years) Cases (a) (b) 
< 1 0 1,717 0 0.013818 0.0 
1-4 0 7,092 0 0.055317 0.0 
5-9 0 9,627 0 0.072532 0.0 
10-14 0 10,404 0 0.073032 0.0 
15-19 0 9,967 0 0.072168 0.0 
20-24 0 6,847 0 0.066478 0.0 
25-29 0 6,445 0 0.064530 0.0 
30-34 0 7,207 0 0.071044 0.0 
35-39 0 8,329 0 0.080762 0.0 
40-44 1 9,221 11 0.081851 0.9 
45-49 0 9,366 0 0.072118 0.0 
50-54 0 7,940 0 0.062716 0.0 
55-59 0 6,334 0 0.048454 0.0 
60-64 1 5,173 19 0.038793 0.7 
65-69 0 4,645 0 0.034264 0.0 
70-74 0 4,444 0 0.031773 0.0 
75-79 0 3,873 0 0.027000 0.0 
80-84 1 2,788 36 0.017842 0.6 
85≤ 0 2,218 0 0.015508 0.0 
Totals 3 123,636 2 1.000000 2.3 
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Table A-2. Colorectal Carcinoma (CRC)—Celina (Age Adjusted Rates) per 100,000 
Age CRC Population Rate per 100,000 Age Adj. Weighted 
group Number (thousands) (b) (c = [a ÷ b] × 100,000) Factor (d) Rate (c × d) 
(years of Cases 
) (a) 
< 1 0 1,717 0 0.013818 0.0 
1-4 0 7,092 0 0.055317 0.0 
5-9 0 9,627 0 0.072532 0.0 
10-14 0 10,404 0 0.073032 0.0 
15-19 0 9,967 0 0.072168 0.0 
20-24 0 6,847 0 0.066478 0.0 
25-29 0 6,445 0 0.064530 0.0 
30-34 0 7,207 0 0.071044 0.0 
35-39 1 8,329 12 0.080762 1.0 
40-44 1 9,221 11 0.081851 0.9 
45-49 0 9,366 0 0.072118 0.0 
50-54 8 7,940 101 0.062716 6.3 
55-59 5 6,334 79 0.048454 3.8 
60-64 8 5,173 155 0.038793 6.0 
65-69 17 4,645 366 0.034264 12.5 
70-74 15 4,444 338 0.031773 10.7 
75-79 19 3,873 491 0.027000 13.2 
80-84 18 2,788 646 0.017842 11.5 
85≤ 14 2,218 631 0.015508 9.8 
Totals 106 123,636 86 1.000000 75.8 
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Table A-3. Hepatocellular Carcinoma (HCC) Cases—Wapakoneta (Age Adjusted Rates) 
per 100,000 
Age HCC Population Rate per 100,000 Weight (d) Weighted 
group Number of (thousands) (c = [a ÷ b] × 100,000) Rate (c × d) 
(years) Cases (a) (b) 
<1 0 1,579 0 0.013818 0.0 
1-4 0 6,521 0 0.055317 0.0 
5-9 0 8,852 0 0.072532 0.0 
10-14 0 9,567 0 0.073032 0.0 
15-19 0 9,165 0 0.072168 0.0 
20-24 0 6,296 0 0.066478 0.0 
25-29 0 5,926 0 0.064530 0.0 
30-34 0 6,627 0 0.071044 0.0 
35-39 0 7,658 0 0.080762 0.0 
40-44 0 8,479 0 0.081851 0.0 
45-49 0 8,613 0 0.072118 0.0 
50-54 1 7,301 14 0.062716 0.9 
55-59 0 5,824 0 0.048454 0.0 
60-64 2 4,757 42 0.038793 1.6 
65-69 0 4,271 0 0.034264 0.0 
70-74 0 4,087 0 0.031773 0.0 
75-79 3 3,561 84 0.027000 2.3 
80-84 0 2,564 0 0.017842 0.0 
85≤ 0 2,040 0 0.015508 0.0 
Totals 6 113,688 5 1.000000 4.8 
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Table A-4. Colorectal Cancer (CRC) Cases—Wapakoneta (Age Adjusted Rates) per 
100,000 
Age CRC Population Rate per 100,000 Weight (d) Weighted 
group Number of (thousands) (c = [a ÷ b] × 100,000) Rate (c × d) 
(years) Cases (a) (b) 
< 1 0 1,579 0 0.013818 0.0 
1-4 0 6,521 0 0.055317 0.0 
5-9 0 8,852 0 0.072532 0.0 
10-14 0 9,567 0 0.073032 0.0 
15-19 0 9,165 0 0.072168 0.0 
20-24 0 6,296 0 0.066478 0.0 
25-29 0 5,926 0 0.064530 0.0 
30-34 0 6,627 0 0.071044 0.0 
35-39 0 7,658 0 0.080762 0.0 
40-44 4 8,479 47 0.081851 3.9 
45-49 5 8,613 58 0.072118 4.2 
50-54 6 7,301 82 0.062716 5.2 
55-59 7 5,824 120 0.048454 5.8 
60-64 9 4,757 189 0.038793 7.3 
65-69 11 4,271 258 0.034264 8.8 
70-74 9 4,087 220 0.031773 7.0 
75-79 20 3,561 562 0.027000 15.2 
80-84 22 2,564 858 0.017842 15.3 
85≤ 9 2,040 441 0.015508 6.8 
Totals 102 113,688 90 1.000000 79.5 
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Table A-5. Hepatocellular Carcinoma (HCC) Cases—Saint Marys (Age Adjusted Rates) 
per 100,000 
Age HCC Population Rate per 100,000 Weight (d) Weighted 
group Number of (thousands) (c = [a ÷ b] × 100,000) Rate (c × d) 
(years) Cases (a) (b) 
<1 0 1,390 0 0.013818 0.0 
1-4 0 5,742 0 0.055317 0.0 
5-9 0 7,794 0 0.072532 0.0 
10-14 0 8,424 0 0.073032 0.0 
15-19 0 8,070 0 0.072168 0.0 
20-24 0 5,544 0 0.066478 0.0 
25-29 0 5,218 0 0.064530 0.0 
30-34 0 5,835 0 0.071044 0.0 
35-39 0 6,743 0 0.080762 0.0 
40-44 0 7,466 0 0.081851 0.0 
45-49 0 7,584 0 0.072118 0.0 
50-54 0 6,429 0 0.062716 0.0 
55-59 0 5,128 0 0.048454 0.0 
60-64 1 4,188 24 0.038793 0.9 
65-69 2 3,761 53 0.034264 1.8 
70-74 0 3,598 0 0.031773 0.0 
75-79 0 3,136 0 0.027000 0.0 
80-84 1 2,257 44 0.017842 0.8 
85≤ 0 1,796 0 0.015508 0.0 
Totals 4 100,104 4 1.000000 3.5 
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Table A-6. Colorectal Cancer (CRC) Cases—Saint Marys (Age Adjusted Rates) per 
100,000 
Age CRC Population Rate per 100,000 Weight (d) Weighted 
group Number of (thousands) (c = [a ÷ b] × 100,000) Rate (c × d) 
(years) Cases (a) (b) 
<1 0 1,390 0 0.013818 0.0 
1-4 0 5,742 0 0.055317 0.0 
5-9 0 7,794 0 0.072532 0.0 
10-14 0 8,424 0 0.073032 0.0 
15-19 0 8,070 0 0.072168 0.0 
20-24 0 5,544 0 0.066478 0.0 
25-29 0 5,218 0 0.064530 0.0 
30-34 0 5,835 0 0.071044 0.0 
35-39 0 6,743 0 0.080762 0.0 
40-44 1 7,466 13 0.081851 1.1 
45-49 5 7,584 66 0.072118 4.8 
50-54 2 6,429 31 0.062716 2.0 
55-59 4 5,128 78 0.048454 3.8 
60-64 6 4,188 143 0.038793 5.6 
65-69 6 3,761 160 0.034264 5.5 
70-74 7 3,598 195 0.031773 6.2 
75-79 13 3,136 415 0.027000 11.2 
80-84 14 2,257 620 0.017842 11.1 
85≤ 13 1,796 724 0.015508 11.2 
Totals 71 100,104 71 1.000000 62.3 
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Table A-7. Age Adjustment Factor for Population of Mercer and Auglaize Counties (2000 
U.S. Census) by Age Group 
Place Mercer Auglaize
County County 
Population* Age Adj. Factor Age Group 
(years) 
<1 7,370 8,051 0.013818 
1-4 30,439 32,264 0.055317 
5-9 41,320 44,010 0.072532 
10-14 44,657 47,956 0.073032 
15-19 42,780 45,567 0.072168 
20-24 29,389 33,094 0.066478 
25-29 27,662 32,363 0.064530 
30-34 30,933 38,182 0.071044 
35-39 35,748 44,245 0.080762 
40-44 39,577 47,553 0.081851 
45-49 40,203 46,546 0.072118 
50-54 34,082 39,663 0.062716 
55-59 27,187 31,662 0.048454 
60-64 22,204 25,076 0.038793 
65-69 19,938 22,066 0.034264 
70-74 19,076 20,820 0.031773 
75-79 16,623 18,450 0.027000 
80-84 11,966 14,363 0.017842 
85≤ 9,521 13,311 0.015508 
Totals 530,675 605,242 1.000000 
*Source: Centers for Disease Control [CDC], National Center for Health Statistics
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Table A-8. Age Adjusted Cumulative Incidence Rates (per 100,000) for Hepatocellular 
Carcinoma (HCC) combined by Age Group 
Place Mercer Auglaize Celina St. Marys Wapakoneta 
County County 
Age Group 
(years) 
<1 0.0 0.0 0.0 0.0 0.0 
1-4 0.0 0.0 0.0 0.0 0.0 
5-9 0.0 0.0 0.0 0.0 0.0 
10-14 0.2 0.0 0.2 0.0 0.0 
15-19 0.0 0.0 0.0 0.0 0.0 
20-24 0.0 0.0 0.0 0.0 0.0 
25-29 0.0 0.0 0.0 0.0 0.0 
30-34 0.0 0.0 0.0 0.0 0.0 
35-39 0.0 0.0 0.0 0.0 0.0 
40-44 0.2 0.0 0.2 0.0 0.0 
45-49 0.2 0.0 0.0 0.0 0.0 
50-54 0.0 0.3 0.0 0.2 0.2 
55-59 0.4 0.0 0.0 0.0 0.0 
60-64 0.5 0.6 0.3 0.2 0.3 
65-69 0.3 0.3 0.3 0.3 0.0 
70-74 0.2 0.0 0.2 0.0 0.0 
75-79 0.2 0.9 0.0 0.0 0.5 
80-84 0.3 0.5 0.1 0.3 0.1 
85≤ 0.5 0.3 0.0 0.0 0.3 
Totals 2.9 3.0 1.4 1.0 1.5 
*Source: CDC, National Center for Health Statistics
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Table A-9. Age Adjusted Cumulative Incidence Rates (per 100,000) for Colorectal Cancer 
(CRC) by Age Group 
Place Mercer Auglaize Celina St. Marys Wapakoneta 
County County 
Age Groups 
(years) 
<1 0.0 0.0 0.0 0.0 0.0 
1-4 0.0 0.0 0.0 0.0 0.0 
5-9 0.0 0.0 0.0 0.0 0.0 
10-14 0.0 0.0 0.2 0.0 0.0 
15-19 0.0 0.0 0.0 0.0 0.0 
20-24 0.0 0.0 0.0 0.0 0.0 
25-29 0.5 0.0 0.2 0.0 0.0 
30-34 0.2 0.0 0.0 0.0 0.0 
35-39 1.1 0.4 0.2 0.2 0.2 
40-44 0.6 2.6 0.4 0.0 1.0 
45-49 1.3 2.0 0.2 1.1 0.7 
50-54 3.9 3.5 1.5 0.4 2.0 
55-59 3.6 4.1 1.1 0.5 1.6 
60-64 6.8 7.0 2.3 1.6 3.0 
65-69 7.2 6.5 2.2 1.4 1.4 
70-74 10.5 6.7 4.2 2.2 3.0 
75-79 10.9 9.2 3.6 2.1 4.7 
80-84 7.6 9.3 3.0 3.4 3.1 
85≤ 7.2 6.3 2.6 1.5 2.3 
Totals 61.3 57.6 21.6 14.3 23.1 
Appendix B. Age Adjusted Cumulative Incidence Rates (per 100,000) 
Place Mercer Auglaize Celina St. Wapakoneta 
County County Marys 
CRC 61.3 57.6 21.6 14.3 23.1 
HCC 2.9 3.0 1.4 1.0 1.5 
Total 64.2 60.6 23.0 15.3 24.6 
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Appendix C. Research Locations—Celina, St. Marys, Wapakoneta 
N 
Celina 
St. Marys 
Wapakoneta 
Grand Lake St. Marys 
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Appendix D. Wright State University IRB Approval 
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Appendix E. Ohio Department of Health IRB Approval 
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Appendix F. Public Health Competencies Met
Specific Competencies 
Domain #1: Analytic Assessment Sk ill 
Defines a problems 
Determines appropriate uses and limitations of both quantitative and qualitative data 
Selects and defines variables relevant to defined public health problems 
Identifies relevant an d appropriate data and in formation so urces 
Evaluates the integrity and compa rability of da ta and identifies gaps in d ata sources 
Applies ethical principles to the collection, mai ntenance, use, and dissemination of data and information 
Partners with communities to attach meaning to collected quantitative and qualitative data 
Makes relevant inferences from quantitative and qualitative data 
Obtains and interprets information regarding risks and benefits to the community 
Applies data collection processes, information technology a pplications, and computer systems 
storage/retrieval stra tegies 
Recognizes how the data illuminates ethical, political, scientific, econom ic, and overa ll public health issues 
Domain #2: Policy D evelopment/Program Planning Skills 
Collects, summarizes, and interprets information relevant to an issue 
States policy options and writes cl ear and conc ise policy statements 
Identifies, interprets, and implements public health laws, re gulations, an d policies rel ated to speci fic 
programs 
Articulates the health, fiscal, admi nistrative, legal, social, and political implications of each policy option 
States the feasibility and expected outcomes of each policy option 
Utilizes current techniques in deci sion analysis and health p lanning 
Decides on the appropriate course of action 
Translates policy into organizational plans, structures, and programs 
Prepares and implements emerge ncy response plans 
Develops mechanism s to monitor and evaluate programs for their effectiveness and quality 
Domain #3: Commun ication Skills 
Communicates effectively both in writing and orally, or in other ways 
Solicits i nput from individuals and organizations 
Advocates for public health programs and reso urces 
Leads and participates in groups to address specific issues 
Uses the media, advanced techno logies, and community networks to communicate information 
Effectively presents accurate dem ographic, statistical, programmatic, an d scientific information for 
professional and lay audiences 
Attitude s 
Listens t o others in an unbiased manner, respe cts points of view of others, and promotes the expression of 
diverse opinions and perspectives 
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Domain #4: Cultural Competency Skills 
Utilizes appropriate methods for interacting sensitively, effectively, and professionally with persons from 
diverse cultural, socioeconomic, educational, racial, ethnic and professional backgrounds, and persons of all 
ages and lifestyle preferences 
Identifies the role of cultural, social, and behavioral factors in determining the delivery of public health 
services 
Develops and adapts approaches to problems that take into account cultural differences 
Attitudes 
Understands the dynamic forces contributing to cultural diversity 
Understands the importance of a diverse public health workforce 
Domain #5: Community Dimensions of Practice Skills 
Establishes and maintains linkages with key stakeholders 
Utilizes leadership, team building, negotiation, and conflict resolution skills to build community partnerships 
Collaborates with community partners to promote the health of the population 
Identifies how public and private organizations operate within a community 
Accomplishes effective community engagements 
Identifies community assets and available resources 
Develops, implements, and evaluates a community public health assessment 
Describes the role of government in the delivery of community health services 
Domain #6: Basic Public Health Sciences Skills 
Identifies the individual’s and organization’s responsibilities within the context of the Essential Public Health 
Services and core functions 
Defines, assesses, and understands the health status of populations, determinants of health and illness, 
factors contributing to health promotion and disease prevention, and factors influencing the use of health 
services 
Identifies and applies basic research methods used in public health 
Identifies and retrieves current relevant scientific evidence 
Identifies the limitations of research and the importance of observations and interrelationships 
Attitudes 
Develops a lifelong commitment to rigorous critical thinking 
Domain #7: Financial Planning and Management Skills 
Monitors program performance 
Manages information systems for collection, retrieval, and use of data for decision‐making 
Domain #8: Leadership and Systems Thinking Skills 
Creates a culture of ethical standards within organizations and communities 
Helps create key values and shared vision and uses these principles to guide action 
Identifies internal and external issues that may impact delivery of essential public health services (i.e. 
strategic planning) 
Facilitates collaboration with internal and external groups to ensure participation of key stakeholders 
Promotes team and organizational learning 
Contributes to development, implementation, and monitoring of organizational performance standards 
Uses the legal and political system to effect change 
Applies the theory of organizational structures to professional practice 
